Omega-3 fatty acids and multiple sclerosis: relationship to depression

Area of Science:

• Neuroscience
• Biochemistry
• Clinical Medicine

Background:

• Depression is a frequent comorbidity in multiple sclerosis (MS).
• Previous studies indicate altered fatty acid levels in MS patients and individuals with major depression.
• The relationship between fatty acid profiles and depression in MS remains unclear.

Purpose of the Study:

• To investigate the association between red blood cell (RBC) fatty acid levels and depression in patients with relapsing-remitting multiple sclerosis (MS).

Main Methods:

• Red blood cell (RBC) fatty acid levels were quantified in 38 MS patients and 33 healthy controls.
• Dietary intake and depression symptoms were assessed using 3-day dietary records and validated questionnaires.
• Statistical analyses were performed to compare fatty acid levels and their correlation with depression scores.

Main Results:

• MS patients exhibited lower levels of certain omega-3 and omega-6 fatty acids and higher levels of certain monounsaturated and saturated fatty acids compared to controls.
• These differences in RBC fatty acid composition were observed irrespective of dietary intake.
• No significant correlation was found between RBC fatty acid levels or dietary fatty acid intake and depression scores in the MS patient group.

Conclusions:

• Multiple sclerosis patients display distinct red blood cell fatty acid profiles compared to healthy individuals, independent of diet.
• Despite these biochemical differences, red blood cell and dietary fatty acid levels are not associated with depression in MS patients.